Cbd Thc Pathways
CBD and THC biosynthesis follows distinct enzymatic pathways that diverge at cannabigerolic acid (CBGA), the common precursor to both major cannabinoids. The CBGA is converted by either CBDAS (cannabidiolic acid synthase) or THCAS (tetrahydrocannabinolic acid synthase), determining whether a plant develops primarily as a CBD-type or THC-type cultivar. Breeders classify plants along this spectrum, though many modern cultivars express both enzymes to varying degrees. Understanding these pathways is fundamental to cannabis genetics work, as they explain phenotypic variation and inform selective breeding strategies for target cannabinoid profiles.
Cbd Thc Pathways strains
No strains tagged into Cbd Thc Pathways yet — they'll appear here as breeders submit lineage records under this terpene.
CBD and THC biosynthesis follows distinct enzymatic pathways that diverge at cannabigerolic acid (CBGA), the common precursor to both major cannabinoids. The CBGA is converted by either CBDAS (cannabidiolic acid synthase) or THCAS (tetrahydrocannabinolic acid synthase), determining whether a plant develops primarily as a CBD-type or THC-type cultivar. Breeders classify plants along this spectrum, though many modern cultivars express both enzymes to varying degrees. Understanding these pathways is fundamental to cannabis genetics work, as they explain phenotypic variation and inform selective breeding strategies for target cannabinoid profiles.
Breeders leverage knowledge of CBD/THC pathway genetics to develop cultivars with specific cannabinoid ratios—from THC-dominant to balanced 1:1 to CBD-dominant types. Marker-assisted selection and understanding enzyme expression patterns allow for more predictable outcomes in breeding programs targeting therapeutic or industrial cannabinoid profiles.
Educational reference · Cultivar metadata only · No medical claims